The downregulation of chemerin expression in malignant adrenocortical carcinoma [197] and acute myeloid leukemia [198] could be assumed as a survival tactic of the cancer cells to evade the immunosuppressive effect of chemerin. Here, RARRES2 is linked to acute myeloid leukemia.